Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment

The good news coincides with big changes at the US specialist pharma company, with a new CEO, AstraZeneca's Mark Mallon, and a splitting out into two separate companies. ... This grants US market exclusivity for the firms until. 2030. , when Mylan will

Latest news

  • US government shutdown leaves FDA running on empty US government shutdown leaves FDA running on empty

    Funding row means shutdown could break 21 day record. The ongoing US government shutdown has left the FDA with just a month of funding left, because it can’t accept any

  • Drug pricing is pharma’s top concern in 2019 Drug pricing is pharma’s top concern in 2019

    Drug pricing and reimbursement remains at the forefront of pharma executive minds as 2019 gets underway, according to a new industry survey. ... One such company is Purdue Pharma, which announced its price increases on 2 January.

  • Orphan drugs dominate FDA's record-breaking year Orphan drugs dominate FDA's record-breaking year

    As 2019 gets under way, the pharma industry and the US FDA can look back at a truly record-breaking 2018 for new drug approvals. ... drugs, driven on by new pharma and biotech science, and the FDA's determination to accelerate its review times.

  • D-day: time to make digital deliver D-day: time to make digital deliver

    The development of digital tools and services is not a traditional strength for pharma. ... Digital D-day is upon us. If pharma gets it right, it really could be a platform for demonstrating and delivering value across the system. .

  • Biogen files Tecfidera follow-up in the US Biogen files Tecfidera follow-up in the US

    In October, a US federal appeals court upheld a ruling that Biogen’s patents on the drug are valid, rejecting a challenge by Danish drugmaker Forward Pharma, with which it had ... Biogen said the ruling meant it had protection against generics in the

More from news
Approximately 7 fully matching, plus 687 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... AstraZeneca is just one of several multinational pharma companies working with China’s homegrown tech companies.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    to encourage a home-grown pharma industry, as well as investment from multinational giant. ... Big pharma reaps the benefits. There is no question that established US and European big pharma companies are also reaping the benefits of the new China boom.

  • Six degrees of participation Six degrees of participation

    The era of Participatory Medicine - aka collaborative care or shared decision-making - is upon us, and fittingly for pharma, it’s the taking part that counts. ... UK, as well as the Head of Digital and therapeutic heads from within the pharma client

  • Health on instalment Health on instalment

    Long-term mortgages democratised home ownership and served as a cornerstone for the US’s much vaunted post-war prosperity. ... Given the animus that exists among US pharma stakeholders, reactions so far have been remarkably conciliatory.

More from intelligence
Approximately 0 fully matching, plus 45 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics